N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration

Abstract

BackgroundNon-coding RNAs have been drawing increasing attention in recent years as functional data suggest that they play important roles in key cellular processes. N-BLR is a primate-specific long non-coding RNA that modulates the epithelial-to-mesenchymal transition, facilitates cell migration, and increases colorectal cancer invasion.ResultsWe performed multivariate analyses of data from two independent cohorts of colorectal cancer patients and show that the abundance of N-BLR is associated with tumor stage, invasion potential, and overall patient survival. Through in vitro and in vivo experiments we found that N-BLR facilitates migration primarily via crosstalk with E-cadherin and ZEB1. We showed that this crosstalk is mediated by a pyknon, a short ~20 nucleotide-long DNA motif contained in the N-BLR transcript and is targeted by members of the miR-200 family. In light of these findings, we used a microarray to investigate the expression patterns of other pyknon-containing genomic loci. We found multiple such loci that are differentially transcribed between healthy and diseased tissues in colorectal cancer and chronic lymphocytic leukemia. Moreover, we identified several new loci whose expression correlates with the colorectal cancer patients’ overall survival.ConclusionsThe primate-specific N-BLR is a novel molecular contributor to the complex mechanisms that underlie metastasis in colorectal cancer and a potential novel biomarker for this disease. The presence of a functional pyknon within N-BLR and the related finding that many more pyknon-containing genomic loci in the human genome exhibit tissue-specific and disease-specific expression suggests the possibility of an alternative class of biomarkers and therapeutic targets that are primate-specific.Electronic supplementary materialThe online version of this article (doi:10.1186/s13059-017-1224-0) contains supplementary material, which is available to authorized users.

Differential expression profile of long non‐coding RNAs in human thoracic aortic aneurysm

“…The expression profile of lncRNAs was closely related to pathological processes, including inflammation, apoptosis, aberrant autophagy, mitochondrial dysfunction, and hypoxic responses. Several lncRNAs had been reported to be potential diagnostic biomarkers or drug targets of cancers . In the present study, the differential expression profile of lncRNAs was detected in TAA for the first time, and some lncRNAs expression levels were found to be correlated with clinical features of TAA patients.…”

Role of miRNAs in immune responses and immunotherapy in cancer

“…Recently, it has been discovered that highly repetitive primate‐specific genomic sequences, called pyknons, are transcribed and can harbor binding sites for miRNAs, consequently working as molecular decoy to buffer the levels of target miRNAs, including immune‐related miRNAs. Particularly, a specific pyknon transcript, pyknon‐90, which is contained inside the primate‐specific long noncoding RNA N‐BLR and overexpressed in colon cancer, harbors the binding site of miR‐200 within its sequence and accordingly can determine the reduction of cellular levels of members of miR‐200's family . Because miR‐200 can target PD‐L1, N‐BLR has the potential to represent a novel and additional level of regulation of immune check point molecules.…”

Epigenetics of gastrointestinal diseases: notes from a workshop

“…George Calin reviewed progress in the discovery and characterization of noncoding RNAs and their relevance to human diseases. By using pattern discovery methods, Dr. Calin’s group identified multiple types of long noncoding RNAs (lncRNAs), including pyknon-transcripts [25]. Pyknons are nonrandom repeated elements found most often in the 3′ untranslated regions of genes.…”